A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT01203943 · TERMINATED

Trial details

NCT number: NCT01203943
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Fibrosis Interstitial Lung Disease Lung Diseases, Interstitial

Start date: 2011-01-01
Primary completion: 2012-01-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.